|Please note: The information in this article reflects our strategic priorities at the time of writing and may change over time. To confirm our current funding interests, please view our Funding Areas.
In June and July 2021, the Board of Trustees of the John Templeton Foundation approved 91 funding requests with an approximate total value of $105 million to support new programs.
Learn more about recent projects we have funded that are now active. These include:
- Investigating how the arrow of time emerges from the building blocks of reality
- How and when children learn how to forgive
- Exploring the health effects of religion and spirituality
- The role that gratitude plays in long-term relationships
- Understanding the limits of our current knowledge
- Developing a global perspective on the philosophy of religion
- Addressing poverty in Philadelphia by supporting entrepreneurs of color
Those interested in applying for funding from the John Templeton Foundation can learn more about our process and funding areas by clicking on the links below. Anyone can submit a request for funding from the Foundation. The next application deadline is August 20, 2021.
- FAQ on our grant process
- Grant application calendar
- Database of existing grants
- Funding areas
- Strategic priorities
- News and information on all Foundation work
Founded in 1987, the John Templeton Foundation supports research and dialogue on the deepest and most perplexing questions facing humankind. The Foundation funds work on subjects ranging from black holes and evolution to creativity, forgiveness, and free will. It also encourages civil, informed dialogue among scientists, philosophers, theologians, and the public at large.
With an endowment of $3.8 billion and annual giving of approximately $140 million, the Foundation ranks among the 25 largest grantmaking foundations in the United States. Headquartered outside Philadelphia, its philanthropic activities have engaged all major faith traditions and extended to more than 190 countries around the world.